Extension of a Computer Assisted Decision Support (CADS) Study to Improve Outcomes in Patients with Type 2 DM Treated Primary Cary Providers

Abstract

The overall aim of this proposal is to test the clinical effects of a Computer Assisted Decision Support (CADS) System for the management of Type 2 diabetes (T2D) by primary care providers (PCPs). Moreover, the aims are to compare longitudinal patterns of change within and between patients who are managed with the CADS system for differing durations. This comparison will help us to understand the clinical utility of using the CADS system continuously or up to a certain threshold of patient improvement. To achieve these aims, we requested a second year of funding (first year funded through United States Army Medical Research Acquisition Activity [USAMRAA], contract number W81XWH-09-2-0196, for a prospective, cluster, randomized controlled trial (RCT). The ongoing project is a multi-site study including the Walter Reed National military Medical Center, Fort Belvoir Community Hospital (FBCH), and the Kimbrough Ambulatory Care Center. The proposal herein is not duplicative of any current study but rather an extension of the already funded one. A detailed, technical explanation of the software and hardware elements of this study are included in reports for the original CADS study and available upon request.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 2013
Accession Number
ADA592839

Entities

People

  • Robert Vigersky

Organizations

  • Walter Reed National Military Medical Center

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Biomedical Research
  • Cardiovascular Physiological Phenomena
  • Computers
  • Decision Support Systems
  • Diabetes
  • Diseases And Disorders
  • Glucose Monitors
  • Health Care
  • Health Services
  • Medical Personnel
  • Monitoring
  • Type 2 Diabetes
  • United States
  • User Manuals

Readers

  • Clinical Trial Research.
  • Medical or Health Care Field.
  • Oncology and Biomarker-Based Cancer Detection.